Schroder Investment Management Group Increases Position in Humana Inc (HUM)

Schroder Investment Management Group boosted its position in Humana Inc (NYSE:HUM) by 62.9% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 95,777 shares of the insurance provider’s stock after acquiring an additional 36,985 shares during the period. Schroder Investment Management Group owned 0.07% of Humana worth $23,250,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. WFG Advisors LP raised its stake in Humana by 4.5% in the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock valued at $113,000 after acquiring an additional 20 shares during the period. Acrospire Investment Management LLC bought a new stake in Humana in the 2nd quarter valued at about $120,000. Northwestern Mutual Wealth Management Co. raised its stake in Humana by 139.5% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock valued at $134,000 after acquiring an additional 325 shares during the period. Fiduciary Trust Co. bought a new stake in Humana in the 2nd quarter valued at about $135,000. Finally, ClariVest Asset Management LLC bought a new stake in Humana in the 3rd quarter valued at about $144,000. Institutional investors and hedge funds own 94.19% of the company’s stock.

Shares of Humana Inc (HUM) traded down $6.25 during midday trading on Tuesday, hitting $252.28. The stock had a trading volume of 2,500,000 shares, compared to its average volume of 1,386,462. Humana Inc has a 52 week low of $186.25 and a 52 week high of $264.56. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $36,933.62, a price-to-earnings ratio of 22.06, a price-to-earnings-growth ratio of 1.78 and a beta of 0.88.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The company had revenue of $13.28 billion during the quarter, compared to analyst estimates of $13.41 billion. During the same quarter in the previous year, the firm earned $3.18 earnings per share. Humana’s revenue was down 3.0% on a year-over-year basis. analysts anticipate that Humana Inc will post 11.63 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Thursday, December 28th. Humana’s payout ratio is 12.59%.

A number of research analysts have weighed in on HUM shares. UBS reaffirmed a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a report on Wednesday, August 9th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a report on Thursday, August 10th. Credit Suisse Group reduced their target price on Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a report on Friday, November 10th. ValuEngine raised Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Finally, BMO Capital Markets started coverage on Humana in a report on Monday, October 16th. They set an “outperform” rating and a $300.00 target price for the company. Twelve investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Humana has a consensus rating of “Hold” and a consensus price target of $255.45.

COPYRIGHT VIOLATION WARNING: This report was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another publication, it was illegally copied and reposted in violation of United States & international trademark & copyright laws. The legal version of this report can be viewed at

Humana Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

What are top analysts saying about Humana Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Humana Inc and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit